CD33 and myeloid sarcoma: In terms of immunohistochemical (IHC) markers that were found in the MS tissue biopsy samples from studies which reported this data, the IHC markers with the highest pooled prevalence were CD33 (79%), CD45 (76%), and MPO (72%) (Figure 2D).